Frederic Checot

Title: Frederic Checot: Innovator in Interferon-Beta Compositions

Introduction

Frederic Checot is a notable inventor based in Taluyers, France. He has made significant contributions to the field of biochemistry, particularly in the development of interferon-beta compositions. His innovative work has led to the creation of a patent that addresses important therapeutic applications.

Latest Patents

Frederic Checot holds a patent for "IFN-beta compositions, preparation methods and uses thereof." This invention pertains to interferon-beta (IFN-beta) compositions that include a grafted poly(glutamic acid) polymer. The polymer has an average molecular weight between 26,000 and 40,000 g/mol and is grafted with alpha-tocopherol substituents. The average molar grafting ratio is between 4.5-5.5 moles %, and the weight/weight ratio between the grafted polymer and IFN-beta ranges from 24 to 125. The invention also covers the preparation methods of these compositions and their application in creating therapeutic compositions that deliver IFN-beta over an extended period.

Career Highlights

Frederic Checot is associated with Ares Trading S.A., where he continues to advance his research and development efforts. His work has been instrumental in enhancing the therapeutic potential of interferon-beta, which is crucial for various medical applications.

Collaborations

Frederic has collaborated with notable colleagues such as Daniel Leblanc and Evert Nicolaas Lamme. These partnerships have contributed to the success and impact of his innovative work in the field.

Conclusion

Frederic Checot's contributions to the development of interferon-beta compositions highlight his role as a significant inventor in the biochemistry sector. His patent reflects a commitment to advancing therapeutic solutions that can benefit patients worldwide.